Key result
Cardiac magnetic field mapping distinguishes myocarditis from healthy controls with ~84% accuracy.
Why the study?
Myocarditis can lead to severe adverse outcomes and sudden cardiac death if undetected, prompting evaluation of cardiac magnetic field mapping as a rapid, non-invasive screening tool before endomyocardial biopsy.
Does cardiac magnetic field mapping quantified by Kullback-Leibler entropy accurately identify patients with clinically suspected myocarditis compared to healthy controls?
Case-Control (n=127)
Yes
Does cardiac magnetic field mapping quantified by Kullback-Leibler entropy accurately identify patients with clinically suspected myocarditis compared to healthy controls?
Cardiac magnetic field mapping quantified by Kullback-Leibler entropy can reliably distinguish between patients with clinically suspected myocarditis and healthy controls, offering a potential non-invasive screening tool.
May support non-invasive myocarditis screening in suspected cases; leaves open validation against biopsy in larger prospective studies.
Background: Myocarditis is a condition that can have severe adverse outcomes and lead to sudden cardiac death if remaining undetected. This study tested the capability of cardiac magnetic field mapping to detect patients with clinically suspected myocarditis. This could open up the way for rapid, non-invasive, and cost-effective screening of suspected cases before a gold standard assessment via endomyocardial biopsy. Methods: = 30) were analyzed using the Kullback-Leibler entropy (KLE) for dimensionality reduction and topological quantification. Linear discriminant analysis was used to discern between patients with ongoing myocarditis and healthy controls. Results: The STT segment of a magnetocardiogram, i.e., the section between the end of the S wave and the end of the T wave, was best suited to discern both groups. Using a 250-ms excerpt from the onset of the STT segment gave a reliable classification between the myocarditis and control group for both historic data (sensitivity: 0.83, specificity: 0.85, accuracy: 0.84) and recent data (sensitivity: 0.69, specificity: 0.88, accuracy: 0.80) using the KLE to quantify the topology of the cardiac magnetic field map. Conclusion: The implementation based on KLE can reliably distinguish between clinically suspected myocarditis patients and healthy controls. We implemented an automatized feature selection based on LDA to replace the observer-dependent manual thresholding in previous studies.
No takes yet. Share an insight, caveat, or question.
Pille et al. (2023) conducted a case-control in Clinically suspected myocarditis (n=127). Cardiac magnetic field mapping (CMFM) vs. Healthy controls was evaluated on Classification accuracy between myocarditis and healthy controls using Kullback-Leibler entropy of the STT segment. Cardiac magnetic field mapping quantified by Kullback-Leibler entropy distinguished myocarditis patients from healthy controls with 84% accuracy in historic data and 80% in recent data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: